Compare NRXP & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRXP | NNBR |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 63.7M |
| IPO Year | N/A | 1994 |
| Metric | NRXP | NNBR |
|---|---|---|
| Price | $2.56 | $1.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $30.50 | N/A |
| AVG Volume (30 Days) | 519.3K | ★ 535.5K |
| Earning Date | 11-17-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $242,000.00 | ★ $424,005,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $821.75 | $5.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.41 | $1.10 |
| 52 Week High | $6.01 | $4.67 |
| Indicator | NRXP | NNBR |
|---|---|---|
| Relative Strength Index (RSI) | 56.82 | 54.99 |
| Support Level | $1.96 | $1.17 |
| Resistance Level | $2.52 | $1.23 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 93.55 | 73.96 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.